所在位置: 人才队伍 >> 研究人员 >>
  • 吴兴新

教授,博导,医药生物技术国家重点实验室 

地址:南京市栖霞区仙林大道163号,210023

邮箱:xingxin.wu@nju.edu.cn









研究领域


免疫病理和免疫药理

化学生物学



工作经历


2018-    南京大学生命科学学院 教授

2018-    南京大学生命科学学院 博士生导师

2019-2021,南京大学国际合作与交流处副处长

2014-2018,南京大学生命科学学院 副研究员

2010-2013,耶鲁大学医学院 博士后研究员



荣誉奖励


2018,教育部高等学校科学研究优秀成果奖自然科学奖一等奖

2018,江苏省教育教学与研究成果奖二等奖

2018,江苏省六大人才高峰

2017,国家优秀青年科学基金获得者

2017,南京大学登峰人才支持计划

2017,罗氏诊断科研成果奖励基金

2017,南京市第十二届自然科学优秀学术论文二等奖



学术任职


2021-,江苏省整合医学研究会理事

2019-,中国药理学会抗炎免疫药理专业委员会青委会副主任委员

2019-,中国药理学会抗炎免疫药理专业委员会委员

2018-,世中联中医药免疫专业委员会常务理事

2017-,中国化学会会员

2016-,中国免疫学会青年委员会委员

2016-,美国免疫学家协会会员

2016-,中国药理学会会员



代表性成果

1.      Yang Tan; Xueqing Sun; Yizhu Xu; Bingjie Tang; Shuaiqi Xu; Dong Lu; Yan Ye; Xiaomin Luo; Xu Diao; Fulong Li; Tianyi Wang; Jiayu Chen; Qiang Xu; Xingxin Wu ; Small molecule targeting CELF1 RNA-binding activity to control HSC activation and liver fibrosis, Nucleic Acids Research, 2022, 50(5): 2440–2451.

2.      Xingxin Wu, Xudong Wu, Yuxiang Ma, Fenli Shao, Yang Tan, Tao Tan, Liyun Gu, Yang Zhou, Beicheng Sun, Yang Sun, Xuefeng Wu, and Qiang Xu. CUG-binding protein 1 regulates HSC activation and liver fibrogenesis. Nature Communications 2016 7, 13498

3.      Yizhu Xu , Huanhuan Wu , Lei Huang , Bingxin Zha, Xiaofei Li, Shuaiqi Xu, Xingxin Wu*, Qihua Zhu*, Qiang Xu*. Rational design, synthesis and biological evaluation of dual PARP-1/2 and TNKS1/2 inhibitors for cancer therapy. European Journal of Medicinal Chemistry, 2022 Jul 5;237:114417. * Co-Corresponding Author

4.      Han Xiao#; Wang Ying#; Sun Jing#; Tan Tao#; Cai Xiaomin; Lin Peinan; Tan Yang; Zheng Bingfeng; Wang Biao; Wang Jiawei; Xu Lingyan; Yu Zhengyi; Xu Qiang*; Wu Xingxin*; Gu Yanhong*; Role of CXCR3 signaling in response to anti-PD-1 therapy, EBioMedicine, 2019, 48: 169-177. * Co-Corresponding Author 

5.      Tan, Y. Xingxin Wu*, Jin Sun, Wenjie Guo, Fangyuan Gong, Fenli Shao, Tao Tan, Yi Cao, Bingfeng Zheng, Yanhong Gu, Yang Sun, and Qiang Xu*. A fumigaclavine C isostere alleviates Th1-mediated experimental colitis via competing with IFN-gamma for binding to IFN-gamma receptor 1. Biochemical pharmacology 2017 123, 63-72.* Co-Corresponding Author 

6.      Shao, F. Tao Tan, Yang Tan, Yang Sun, Xingxin Wu*, and Qiang Xu*. Andrographolide alleviates imiquimod-induced psoriasis in mice via inducing autophagic proteolysis of MyD88. Biochemical pharmacology 2016 115, 94-103.* Co-Corresponding Author 

7.      Wu Xingxin; Lahiri Amit; Sarin Ritu; Abraham Clara*; T cell-extrinsic CD18 attenuates antigen-dependent CD4+ T cell activation in vivo, Journal of Immunology, 2015, 194(9): 4122-4129. 

8.      Xingxin Wu, Amit Lahiri, G Kenneth 3rd Haines, Richard A Flavell, Clara Abraham*, NOD2 regulates CXCR3-dependent CD8+ T cell accumulation in intestinal tissues with acute injury, Journal of Immunology, 2014, 192(7): 3409-3418.

9.      Wu Xingxin, Guo WJ, Wu LM et al. Selective sequestration of STAT1 in the cytoplasm via phosphorylated SHP-2 ameliorates Th1-mediated murine colitis. Journal of Immunology 2012;189:3497-507. (IF: 5.79)

10.   Ritu Sarin, Xingxin Wu, Clara Abraham, Inflammatory disease protective R381Q IL23 receptor polymorphism results in decreased primary CD4+ and CD8+ human T-cell functional responses. Proc Natl Acad Sci U S A, 2011, 108:9560-5.


团队风采